Deciphera Pharmaceuticals Inc (DCPH.OQ)
DCPH.OQ on NASDAQ Stock Exchange Global Select Market
23.69USD
25 Jun 2019
23.69USD
25 Jun 2019
Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$23.69
$23.69
Open
$24.08
$24.08
Day's High
$24.25
$24.25
Day's Low
$23.41
$23.41
Volume
68,393
68,393
Avg. Vol
64,451
64,451
52-wk High
$43.90
$43.90
52-wk Low
$18.56
$18.56
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Mar '19 | 0.00 | -1.245 |
| FY 2018 | Dec '18 | 0.00 | -0.857 |
| Sep '18 | 0.00 | -0.649 | |
| Jun '18 | 0.00 | -0.646 | |
| Mar '18 | 0.00 | -0.657 | |
| FY 2017 | Dec '17 | 0.00 | -0.649 |
| Sep '17 | 0.00 | -0.392 | |
| Jun '17 | 0.00 | -0.346 | |
| Mar '17 | 0.00 | -0.251 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 9 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Sep-19 | 9 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-19 | 9 | 0.00 | 0.00 | 0.00 | 18.75 |
| Year Ending Dec-20 | 9 | 19.98 | 110.00 | 0.70 | 21.77 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 9 | -1.12 | -0.99 | -1.31 | -0.78 |
| Quarter Ending Sep-19 | 9 | -1.12 | -0.95 | -1.29 | -0.77 |
| Year Ending Dec-19 | 9 | -4.57 | -3.66 | -5.16 | -2.69 |
| Year Ending Dec-20 | 9 | -4.32 | -2.46 | -5.72 | -3.37 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 105.08 | 37.43 | |
| P/E High - Last 5 Yrs. | -- | 161.51 | 57.63 | |
| P/E Low - Last 5 Yrs. | -- | 50.96 | 28.63 | |
| Beta | -- | 1.19 | 0.96 | |
| Price to Sales (TTM) | -- | 42.20 | 11.40 | |
| Price to Book (MRQ) | 3.80 | 12.51 | 4.51 | |
| Price to Tangible Book (MRQ) | 3.80 | 18.39 | 5.33 | |
| Price to Cash Flow (TTM) | -- | 69.26 | 26.01 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.10 | 1.63 | |
| Dividend Yield - 5 Year Avg | -- | 0.05 | 1.34 | |
| Dividend 5 Year Growth Rate | -- | 0.76 | 6.49 | |
| Payout Ratio(TTM) | -- | 1.44 | 39.39 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 58.30 | 15.39 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 43.69 | 8.59 | |
| Sales - 5 Yr. Growth Rate | -- | 33.23 | 10.45 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -89.37 | -8.72 | 18.61 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -66.09 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 22.00 | 7.11 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 24.47 | 7.94 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.74 | 2.47 |
| Current Ratio (MRQ) | 9.55 | 3.73 | 3.43 |
| LT Debt to Equity (MRQ) | 0.45 | 7.72 | 14.20 |
| Total Debt to Equity (MRQ) | 0.53 | 21.14 | 19.91 |
| Interest Coverage (TTM) | -708.26 | 36.20 | 15.22 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 26.58 | 49.98 | |
| Gross Margin - 5 Yr. Avg. | -- | 59.79 | 51.20 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -6.12 | 16.26 | |
| Operating Margin (TTM) | -- | -108.65 | -10.68 | |
| Operating Margin - 5 Yr. Avg. | -- | -22.51 | 11.50 | |
| Pre-Tax Margin (TTM) | -- | -109.92 | -11.19 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -28.14 | 16.37 | |
| Net Profit Margin (TTM) | -- | -115.55 | -14.99 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -33.56 | 11.51 | |
| Effective Tax Rate (TTM) | -- | 17.24 | 20.16 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.85 | 24.36 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 0 | 8,233,076 | 787,598,893 | |
| Net Income/Employee (TTM) | -1,123,286 | 1,744,472 | 92,737,716 | |
| Receivable Turnover (TTM) | -- | 10.88 | 5.82 | |
| Inventory Turnover (TTM) | -- | 2.42 | 3.69 | |
| Asset Turnover (TTM) | 0.00 | 0.33 | 0.81 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -55.69 | 6.38 | 9.73 | |
| Return on Assets - 5 Yr. Avg. | -- | 6.28 | 10.65 | |
| Return on Investment (TTM) | -61.72 | 7.78 | 12.14 | |
| Return on Investment - 5 Yr. Avg. | -- | 8.23 | 13.55 | |
| Return on Equity (TTM) | -62.19 | 8.33 | 17.05 | |
| Return on Equity - 5 Yr. Avg. | -- | 9.24 | 15.09 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -72.12 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Deciphera Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 0.76 | -3.32 | 99 | 99 |
| 13 Week | -0.87 | -5.82 | 99 | 75 |
| 26 Week | 18.66 | -5.28 | 99 | 36 |
| 52 Week | -39.70 | -43.60 | 89 | 8 |
| YTD | 13.63 | -3.29 | 99 | 17 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 60.84% |
| # of Holders: | 121 |
| Total Shares Held: | 23,233,100 |
| 3 Mo. Net Change: | 847,840 |
| # New Positions: | 16 |
| # Closed Positions: | 9 |
| # Increased Positions: | 49 |
| # Reduced Positions: | 43 |
| # Net Buyers: | 6 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.